A new study confirms that the oral treatment for Fabry disease, Galafold (migalastat), is effective in pediatric patients ...

HLB Global is pulling together Korean medtech firms and Japanese capital to knit together cross-border medical data and build ...

Korea’s birth rate appears to be experiencing a modest rebound, with the number of babies born in April posting the sharpest ...

Professor Yoon Jin-a of the Department of Rehabilitation Medicine at Pusan National University Hospital (PNUH) will receive 6 ...

Gachon University Gil Medical Center invited five Mongolian children with congenital heart disease to undergo free surgery.

Pharos iBbio said Tuesday that PHI-101, its next-generation indigenous acute myeloid leukemia drug, has received orphan drug designation from the European Medicines Agency (EMA).The designation is not ...

AbbVie’s JAK inhibitor Rinvoq (ingredient: upadacitinib) has become the first drug in its class to receive reimbursement for ...

Seoul National University Hospital (SNUH) said Tuesday that it has successfully performed the first high-risk ovarian cancer ...

“We can end HIV epidemic. But before that, we must break down the invisible walls built by fear and misunderstanding.”Ryan ...

Despite the rapid growth of Korea’s biopharmaceutical market, the government's approval system to support it still relies on ...

ABION BIO, a Korea-based biopharmaceutical company, said it has entered into a licensing and co-development agreement worth ...

ABL Bio has built a new headquarters in Gangnam, Seoul, anchoring its "Vision ABL 2.0."In an interview with Korea Biomedical ...